{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T01:56:26Z","timestamp":1784598986711,"version":"3.55.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"Supplement_6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Sarcoidosis is a systemic granulomatous disease that primarily affects the lung; it is associated with significant disparities, more commonly impacting those in the prime of their lives (age 20\u201350 yr, with a second peak after age 60 yr), black individuals, and women. However, the burden of disease, the ability to diagnose and prognose organ involvement and course, as well as specific treatment options, management options, and disease pathogenesis remain poorly understood. As a result, the National Heart, Lung, and Blood Institute undertook a sarcoidosis workshop, \u201cLeveraging Current Scientific Advancements to Understand Sarcoidosis Variability and Improve Outcomes,\u201d to help address these issues by defining the scientific and clinical priorities to improve sarcoidosis care. The overarching recommendations from this workshop are outlined in the following summary and detailed in the accompanying articles. The recommendations included establishing collaborations and networks to conduct research based on consensus definitions of disease phenotypes and standards of care, and to provide clinical outreach to areas with a burden of disease to improve care. These collaborative networks would also serve as the hub to conduct clinical trials of devastating phenotypes (e.g., cardiac, neurologic, and fibrotic disease) not only for treatment but to enhance our understanding of the burden of disease. In addition, the networks would be used to leverage state-of-the-art \u201comics\u201d and systems biology research, as well as other studies to advance understanding of disease pathogenesis, and development of biomarkers and therapeutic targets, with a goal to translate this information to improve care of individuals with sarcoidosis.<\/jats:p>","DOI":"10.1513\/annalsats.201707-563ot","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T16:18:02Z","timestamp":1508429882000},"page":"S415-S420","source":"Crossref","is-referenced-by-count":27,"title":["Executive Summary of the NHLBI Workshop Report: Leveraging Current Scientific Advancements to Understand Sarcoidosis Variability and Improve Outcomes"],"prefix":"10.1093","volume":"14","author":[{"given":"Lisa A.","family":"Maier","sequence":"first","affiliation":[{"name":"Division of Environmental and Occupational Health Sciences, National Jewish Health, Denver, Colorado"},{"name":"Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliott D.","family":"Crouser","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"William J.","family":"Martin","sequence":"additional","affiliation":[{"name":"College of Public Health, Ohio State University, Wexner Medical Center, Columbus, Ohio; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Eu","sequence":"additional","affiliation":[{"name":"Division of Lung Diseases, National Heart, Lung, and Blood Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,12,1]]},"reference":[{"key":"2026020403043478000_bib1","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.rmed.2012.02.007","article-title":"Unexpectedly high prevalence of sarcoidosis in a representative U.S. metropolitan population","volume":"106","author":"Erdal","year":"2012","journal-title":"Respir Med"},{"key":"2026020403043478000_bib2","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1164\/rccm.201010-1679OC","article-title":"Sarcoidosis-related mortality in the United States from 1988 to 2007","volume":"183","author":"Swigris","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020403043478000_bib3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1164\/rccm.200308-1073WS","article-title":"Future directions in sarcoidosis research: summary of an NHLBI working group","volume":"170","author":"Martin","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020403043478000_bib4","doi-asserted-by":"crossref","first-page":"S445","DOI":"10.1513\/AnnalsATS.201707-567OT","article-title":"Application of \u201comics\u201d and systems biology to sarcoidosis research","volume":"14","author":"Crouser","journal-title":"Ann Am Thorac Soc"},{"key":"2026020403043478000_bib5","doi-asserted-by":"crossref","first-page":"S421","DOI":"10.1513\/AnnalsATS.201707-564OT","article-title":"Disease burden and variability in sarcoidosis","volume":"14","author":"Gerke","journal-title":"Ann Am Thorac Soc"},{"key":"2026020403043478000_bib6","doi-asserted-by":"crossref","first-page":"S429","DOI":"10.1513\/AnnalsATS.201707-565OT","article-title":"Genetic, immunologic, and environmental basis of sarcoidosis","volume":"14","author":"Moller","journal-title":"Ann Am Thorac Soc"},{"key":"2026020403043478000_bib7","doi-asserted-by":"crossref","first-page":"S437","DOI":"10.1513\/AnnalsATS.201707-566OT","article-title":"High-risk sarcoidosis: current concepts and research imperatives","volume":"14","author":"Sauer","journal-title":"Ann Am Thorac Soc"},{"key":"2026020403043478000_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12016-015-8481-z","article-title":"Etiologies of sarcoidosis","volume":"49","author":"Chen","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"2026020403043478000_bib9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ccm.2015.08.002","article-title":"Genetics of sarcoidosis","volume":"36","author":"Fingerlin","year":"2015","journal-title":"Clin Chest Med"},{"key":"2026020403043478000_bib10","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1513\/AnnalsATS.201503-172OT","article-title":"Rationale and design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) Study: sarcoidosis protocol","volume":"12","author":"Moller","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"2026020403043478000_bib11","first-page":"147","article-title":"Pulmonary and psychosocial findings at enrollment in the ACCESS Study","volume":"22","author":"Yeager","year":"2005","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026020403043478000_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.39480","article-title":"2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2026020403043478000_bib13","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/aje\/kwm021","article-title":"The third generation cohort of the National Heart, Lung, and Blood Institute\u2019s Framingham Heart Study: design, recruitment, and initial examination","volume":"165","author":"Splansky","year":"2007","journal-title":"Am J Epidemiol"},{"key":"2026020403043478000_bib14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1378\/chest.10-0413","article-title":"Sarcoidosis in black women in the United States: data from the Black Women\u2019s Health Study","volume":"139","author":"Cozier","year":"2011","journal-title":"Chest"},{"key":"2026020403043478000_bib15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1750-1172-8-48","article-title":"Experimental designs for small randomised clinical trials: an algorithm for choice","volume":"8","author":"Cornu","year":"2013","journal-title":"Orphanet J Rare Dis"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/14\/Supplement_6\/S415\/66716140\/annalsats_14_supplement_6_s415.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/14\/Supplement_6\/S415\/66716140\/annalsats_14_supplement_6_s415.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T08:04:44Z","timestamp":1770192284000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/14\/Supplement_6\/S415\/8454176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,1]]},"references-count":15,"journal-issue":{"issue":"Supplement_6","published-online":{"date-parts":[[2017,12,1]]},"published-print":{"date-parts":[[2017,12,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201707-563ot","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,12]]},"published":{"date-parts":[[2017,12,1]]}}}